Should Massively Parallel Sequencing Be Used to Screen for Maturity-Onset Diabetes of the Young? – Endocrinology Advisor

The use of targeted massively parallel sequencing to screen children with diabetes for maturity-onset diabetes of the young is more effective and less costly than the current standard care and may improve patient quality of life.

Source: Should Massively Parallel Sequencing Be Used to Screen for Maturity-Onset Diabetes of the Young? – Endocrinology Advisor

About the Author

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. The RDNutriScape Instagram

Tags:

Related Posts